Live Breaking News & Updates on Proteasome inhibitor

Stay updated with breaking news from Proteasome inhibitor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

The phase 3 study findings supported belantamab mafodotin as a potential new standard of care in the second line or later among patients with released/refractory multiple myeloma. ....

Salamanca , Castillay-leóp , Spain , Maria-victoria-mateos , University-hospital-of-salamanca , University-hospital , Multiple-myeloma , Yeloma , Plasma-cell-myeloma , Refractory , Proteasome-inhibitor , Bortezomib

Idecabtagene Vicleucel Approaches EU Approval in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

The EMA's CHMP has recommended the approval of idecabtagene vicleucel in patients with multiple myeloma who received at least 2 prior therapies. ....

Anne-kerber , International-staging-system , Oncologic-drugs-advisory-committee , Late-clinical-development , European-commission , Bristol-myers-squibb , European-medicines-agency , Medicinal-products , Human-use , Cell-therapy , Revised-international-staging-system , Drugs-advisory-committee

This Frontline Therapy Is Better in Multiple Myeloma: Study

A study directly comparing real-world outcomes suggests patients with transplant-ineligible multiple myeloma do better with frontline triple therapy with daratumumab vs bortezomib. ....

United-states , Florida , American , Dorisk-hansen , American-society-of-hematology , National-comprehensive-cancer-network , Moffitt-cancer-center-research-institute-in-tampa , Moffitt-cancer-center , Research-institute , American-society , Multiple-myeloma

Myeloma: Isatuximab 4-Drug Regimen Boosts MRD Negativity

'This [research] builds on our experience that four-drug combinations with a monoclonal antibody, proteasome inhibitor, immunomodulatory drug, and steroids are superior to three-drug combinations.' ....

Boston , Massachusetts , United-states , Italy , Dana-farber-cancer-institute , American , Bristol-myers-squibb-celgene , Joseph-mikhael , Irene-ghobrial , Pfizer , City-of-hope-cancer-center , American-society-of-hematology

ELREXFIO™ (elranatamab-bcmm), Now Available from Onco360

ELREXFIO™ (elranatamab-bcmm), Now Available from Onco360
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Kentucky , Benito-fernandez , National-cancer-institute-surveillance , National-comprehensive-cancer-network , Pfizer-inc , Pfizer , End-results-program , Pharmerica-corporation , Drug-administration , Has-received , Accelerated-approval